Team Novo Nordisk begins 2014 season at Tour de San Luis

, the world’s first all- team, begins its second season on January, 20, 2014 at the . In its inaugural season, Team Novo Nordisk achieved 22 top-ten finishes, including three third-place podium finishes, one at and two at .

– The roster for includes, Andrea Peron (ITA), who achieved 13 top ten finishes including podium finishes at the and in the 2013 season; David Lozano (ESP), a former 11-time Spanish in mountain-bike and cyclocross; Kevin de Mesmaeker (BEL), Chris Williams (AUS), and team veterans (ESP) and Martijn Verschoor (DEN).

“We are looking forward to beginning our 2014 season at the . We hope that ’s participation in the race will inspire people and show the world what may be possible when you have .” – , co-founder and CEO, .

“We are very excited to be competing against some of the best cyclists in the world at the . This is a very high profile race and the world will be watching us. Following a successful first season as , we are hoping to achieve even greater race results this year and inspire more people affected by .” – Vassili Davidenko, Corporate Vice President of Athletic Operations and General Manager, .

– The men’s team includes all- from 10 different countries and is at the forefront of , a global all- sports team of cyclists, triathletes and runners. The team’s mission is to inspire, educate and empower people affected by .

– Since its launch in December 2012, has competed in more than 55 races, spanning more than 9,500 km across 15 countries, meeting and inspiring thousands of people affected by across the world.

– The full professional men’s team roster for 2014 includes: Aaron Perry (NZL), Andrea Peron (ITA), Ben Dilley (USA), Charles Planet (FRA), Chris Williams (AUS), David Lozano (ESP), (ESP), Joe Eldridge (USA), Joonas Henttala (FIN), Justin Morris (AUS), Kevin de Mesmaeker (BEL), Martijn Verschoor (DEN), Nicolas Lefrancois (FRA), Paolo Cravanzola (ITA), Ruud Cremers (NED), Stephen Clancy (IRE), and Thomas Raeymaekers (BEL).

Add to the conversation! Leave your comment here.